Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
12/2008
12/25/2008US20080318922 Bicyclic Pyrrole Derivatives
12/25/2008US20080318920 Deuterium-enriched ezetimibe
12/25/2008US20080318916 Novel alpha glucosidase inhibitors from lichens
12/25/2008US20080318908 Use of gaba and gabab agonists
12/25/2008US20080318897 Composition Containing Swelling Agent Composed of Swellable Water-Soluble Polysaccharide, and Food, Anti-Obesity Agent and Constipation Alleviator Each Containing the Composition
12/25/2008US20080318874 Novel Cyclohexane Derivative, Prodrug Thereof and Salt Thereof, and Therapeutic Agent Containing the Same for Diabetes
12/25/2008US20080318870 Synthetic bile acid compositions and methods
12/25/2008US20080318866 Medicament for treatment of non-insulin dependent diabetes mellitus, hypertension and/or metabolic syndrome
12/25/2008US20080318861 Mucosal Delivery of Stabilized Formulations of Exendin
12/25/2008US20080318851 Acid-labile subunit (ALS) of insulin-like growth factor binding protein complex
12/25/2008US20080318845 Selective Vpac2 Receptor Peptide Agonists
12/25/2008US20080318838 Peptides
12/25/2008US20080318202 Chimeric pancreas
12/25/2008US20080317888 lignan extract comprising a lignan complex including secoisolariciresinol diglucoside;wherein the lignan extract is substantially free of cyanogenic glycosides as determined by measuring free cyanides; use in treating cancer, diabetes, hypertension, lupus, and atherosclerosis
12/25/2008US20080317882 Composistion Comprising Fremented tea Extract as the Main Component and Having Effect of Elevation Adiponectin Level
12/25/2008US20080317880 Plant isoflavone and isoflavanone o-methyltransferase genes
12/25/2008US20080317868 Composition for improving membrane composition and functioning cells
12/25/2008US20080317847 Hydrostatic delivery system for controlled delivery of agent
12/25/2008US20080317767 Tripartitle Raftophilic Strutures and their Use
12/25/2008US20080317734 Nutraceutical compositions and methods with biologically active ingredients
12/25/2008US20080317726 Proteases for Pharmaceutical Use
12/25/2008US20080317701 Phosphate Ion Adsorbent
12/24/2008WO2008157752A1 Spirocycles as inhibitors of 11-beta hydroxyl steroid dehydrogenase type 1
12/24/2008WO2008157635A2 Synthetic bile acid composition, method, and preparation
12/24/2008WO2008156869A2 Sirtuin modulating thiazolopyridine compounds
12/24/2008WO2008156866A1 Sirtuin modulating imidazothiazole compounds
12/24/2008WO2008156601A1 Tricyclic inhibitors of hydroxysteroid dehydrogenases
12/24/2008WO2008156174A1 Pyrazinamide compound
12/24/2008WO2008156142A1 Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
12/24/2008WO2008156102A1 Pyrazolone derivative and pde inhibitor containing the same as active ingredient
12/24/2008WO2008155900A1 Glp-1 peptide having sugar chain attached thereto
12/24/2008WO2008155467A1 Transmembrane prostatic acid phosphatase
12/24/2008WO2008155403A2 Use of leptin in the prevention of unhealthy food habits and cardiovascular diseases
12/24/2008WO2008129529A3 Cannabinoid for the treatment of neuronal damage in diabetic patients
12/24/2008WO2008070692A8 Bicyclic compounds and use as antidiabetics
12/24/2008WO2008060476A3 Nitrogen-containing heterocyclic compounds and methods of use thereof
12/24/2008WO2008057529A3 Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (cetp)
12/24/2008WO2008019368A3 Albumin-insulin fusion proteins
12/24/2008EP2006300A2 Characterization of a calcium channel family
12/24/2008EP2006286A2 Isoxazole derivative and isothiazole derivative having inhibitory activity on 11 beta -hydroxysteroid dehydrogenase type i
12/24/2008EP2006284A1 Dicyclooctane derivates, preparation processes and medical uses thereof
12/24/2008EP2005994A1 Functional foodstuff product
12/24/2008EP2005967A1 Use of leptin in the treatment of alterations in food habits
12/24/2008EP2005964A2 The medicament for treating hyperphospheremia and preparation thereof
12/24/2008EP2004658A1 Condensed imidazole derivatives as aromatase inhibitors
12/24/2008EP2004657A1 Condensed imidazole derivatives as aldosterone synthase inhibitors
12/24/2008EP2004643A1 Organic compounds
12/24/2008EP2004619A1 1-phenylsulfonyl-diaza heterocyclic amide compounds and their uses as modulators of hydroxsteroid dehydrogenases
12/24/2008EP2004617A2 Ceramide kinase modulation
12/24/2008EP2004604A1 Substituted phenylpiperidine derivatives as melanocortin-4 receptor modulators
12/24/2008EP2004597A2 1alpha-hydroxy-2-(3'-hydroxypropylidene)-19-nor-vitamin d compounds with a 1,1-dimethylpropyl side chain
12/24/2008EP2004593A1 Improved crystalline material
12/24/2008EP2004186A2 Varenicline standards and impurity controls
12/24/2008EP2004152A2 Multi-membrane immunoisolation system for cellular transplant
12/24/2008EP2004138A1 Gastric raft composition comprising preferably processed starches for inducing satiety
12/24/2008EP2003991A1 Novel nutraceutical compositions
12/24/2008EP2003966A2 Anthracenedione compounds
12/24/2008EP1627866B1 Carboxylic acid compound and medicine containing the same
12/24/2008EP1620425B1 Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists
12/24/2008EP1601669B1 Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
12/24/2008EP1503996B1 Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
12/24/2008EP1441746B1 Composition and method
12/24/2008EP1178785B1 Compositions and methods for identifying antigens which elicit an immune response
12/24/2008DE102007029042A1 Pharmazeutische Zusammensetzung mit einem Trihydroxychromenone-Derivate A pharmaceutical composition comprising a Trihydroxychromenone derivatives
12/24/2008CN101331131A Pyrrolo [2, 3-b] pyridine derivatives as h3 receptor modulators
12/24/2008CN101331122A Salts of modulators of PPAR and methods of treating metabolic disorders
12/24/2008CN101331120A Novel heterocycle compounds
12/24/2008CN101330929A Inhibitor of transplanted islet dysfunction in islet transplantation
12/24/2008CN101330921A An extract from xylocarpus useful for the treatment of diabetes and dyslipidemia
12/24/2008CN101330919A Pharmaceutical composition including (E)-7-[4-(4-fluorophenyl)-6-isopropyl-2- [methyl(methylsulfonyl)amino]pyrim idin-5-yl]-(3R, 5S)-3,5-dihydroxyhept-6-enoic acid
12/24/2008CN101328487A Preparation of fermentation liquor of Coprinus comatus liquid conversion mulberry leaf and use thereof
12/24/2008CN101328472A Epidermal growth factor culture fluid, externally used drug for curing diabetes trauma using the culture fluid and preparation of the externally used drug
12/24/2008CN101328470A Rhamnose bacterium lacticum grx10 having cholesterol lowering and antibacterial functions, preparation and use thereof
12/24/2008CN101328221A Hypoglycemic polypeptide fused protein, structure and use of derivate thereof
12/24/2008CN101328157A Substituted n-phenyl 2-hydroxy-2-methyl-3,3,3-trifluropropanamide derivatives which elevate pyruvate dehydrogenase activity
12/24/2008CN101328152A Piperazidine compound and pyridine compound
12/24/2008CN101327321A Soft capsules containing lactase
12/24/2008CN101327316A Formulation for treating and preventing acalcerosis
12/24/2008CN101327310A Chinese medicinal composition for treating hyperlipemia and preparation thereof
12/24/2008CN101327303A Long life fat-reducing navel plaster
12/24/2008CN101327301A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327300A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327299A Pharmaceutical combination for preventing birth-defect and improving memory and intelligence
12/24/2008CN101327292A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327291A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327290A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327285A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327251A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327246A Radix astragali medicinal materials, intermediate body and method for testing fingerprint of formulation thereof as well as standard fingerprint
12/24/2008CN101327244A Decolored and debitterized Momordica grosvenori extract and preparation method thereof
12/24/2008CN101327243A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327240A Pharmaceutical combination for preventing birth-defect and improving memory
12/24/2008CN101327239A Pharmaceutical combination of prepotency for preventing birth-defect and improving memory
12/24/2008CN101327232A Method for preparing Hippophae rhamnoides flavones separated and purified by polyamide and uses thereof
12/24/2008CN101327230A Oral medicament for treating diabetes
12/24/2008CN101327228A Low-acid gingko flavones and extracting method thereof
12/24/2008CN101327225A Bee honey acid composition and preparation method and uses thereof
12/24/2008CN101327221A Medical use of Ophiopogon root saponin D as tissue factor pathway inhibitor
12/24/2008CN101327214A Medicine use of isoquinoline alkaloids as tissue factor inhibitor
12/24/2008CN101327210A Use of black bean peel anthocyanidin in preparing medicament or food for preventing and treating diabetes and vascular complication